Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The prevalence of cardiogenic shock (CS) resulting from the progression of heart failure (PHF) is increasing and remains associated with high mortality. This study aimed to compare the clinical characteristics and outcomes of patients who developed CS due to PHF versus those whose CS was caused by other aetiologies (non-PHF). We retrospectively analysed 280 patients admitted to a Polish tertiary care centre between January 2021 and April 2024. The cohort was divided into two groups: PHF ( = 84, 30%) and non-PHF ( = 196, 70%). Compared to the non-PHF group, PHF patients more frequently had chronic kidney disease (30% vs. 15%, < 0.01), and significant valvular disease (30% vs. 13%, < 0.01). PHF patients exhibited significantly lower white blood cell counts (9.4 [6.9-16.4] vs. 13.3 [10.4-17.6], < 0.01) and troponin T levels (188 [61-1392] vs. 10,921 [809-45,792], < 0.01). In-hospital mortality was significantly lower among PHF patients (52% vs. 65%, = 0.04). Although the overall use of mechanical circulatory support (MCS) did not differ between groups, significant differences in the types of MCS applied were observed ( < 0.01). Additionally, PHF patients underwent fewer coronary revascularisation procedures (15% vs. 70%, < 0.01). Patients with PHF-related CS exhibit distinct clinical profiles and may experience lower in-hospital mortality when appropriately diagnosed and treated with a personalised approach. Further prospective, multicentre studies are warranted to optimize the management of this growing subgroup of CS patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12383962 | PMC |
| http://dx.doi.org/10.3390/biomedicines13081856 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Post-reduction reclassification dilemma in proximal humeral fracture-dislocation: A case report and practical considerations.
Int J Surg Case Rep
September 2025
Institute of Orthopedics and Traumatology, Military Hospital 175, Ho Chi Minh City, 70000, Viet Nam. Electronic address:
Introduction: Proximal humeral fracture-dislocations (PHF-D) are complex injuries, often requiring urgent intervention. However, management protocols remain unclear when anatomical reduction of the glenohumeral joint is achieved, but significant displacement of the greater tuberosity persists. The lack of consensus on whether to reclassify such injuries after reduction creates uncertainty in rehabilitation strategies.
View Article and Find Full Text PDFRisk factors for cephalic necrosis after plate and screw osteosynthesis of 3- and 4-part proximal humerus fractures: prospective cohort study of 121 patients.
Musculoskelet Surg
August 2025
Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Purpose: Avascular necrosis (AVN) of the humeral head is a relatively frequent complication after proximal humerus fractures (PHF), often leading to poor outcomes and reoperation. This study investigates both non-modifiable (fracture type, trauma energy, age, sex, Charlson comorbidity index) and modifiable (surgical access, bone graft use, reduction quality) risk factors for post-operative AVN in Neer 3-4-part PHFs.
Methods: Patients with Neer 3-4-part PHFs treated using angular stable plates and followed for at least 6 months were included.
Clinical, patient-reported, and radiographic outcomes of proximal humerus open reduction internal fixation augmented with calcium sulfate hydroxyapatite bio-composite (CERAMENT BONE VOID FILLER).
Injury
August 2025
Department of Orthopaedic Surgery, University Hospitals, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106, USA.
Introduction: To minimize the complications associated with proximal humerus open reduction internal fixation (ORIF), various augmentation strategies have been utilized to manage humeral head bone loss. The purpose of the study is to report clinical and patient reported outcomes of calcium sulfate hydroxyapatite bio-composite bone void filler augmentation of proximal humerus ORIF.
Methods: A prospective cohort of patients who sustained a proximal humerus fracture (PHF) treated with ORIF were collected between 2022-2024.
Cardiogenic Shock Due to Progressive Heart Failure-Clinical Characteristics and Outcomes Compared to Other Aetiologies.
Biomedicines
July 2025
Jan Mikulicz Radecki University Hospital, Borowska 213, 50-556 Wroclaw, Poland.
The prevalence of cardiogenic shock (CS) resulting from the progression of heart failure (PHF) is increasing and remains associated with high mortality. This study aimed to compare the clinical characteristics and outcomes of patients who developed CS due to PHF versus those whose CS was caused by other aetiologies (non-PHF). We retrospectively analysed 280 patients admitted to a Polish tertiary care centre between January 2021 and April 2024.
View Article and Find Full Text PDFIs postoperative ketorolac administration associated with nonunion in adults after proximal humerus open reduction and internal fixation? a propensity-matched retrospective cohort study.
Injury
August 2025
Department of Orthopaedic Surgery, Cleveland Clinic Akron General, Akron, OH, USA.
Introduction: Although ketorolac's association with poor bone healing remains debated, no study has examined the impact of ketorolac administration in adults with proximal humerus fractures (PHFs) after open reduction and internal fixation (ORIF), limiting surgeon decision-making. Therefore, the primary aim of this study was to examine the association between short-term ketorolac administration within the first three days after ORIF for PHF and the incidence and risk of nonunion or malunion through one year.
Methods: A pre-registered retrospective propensity-matched cohort study was performed using a large United States health records-based database (TriNetX, LLC).